Focal segmental glomerulosclerosis and Guillain-Barre syndrome associated with Campylobacter enteritis

Internal Medicine Journal

Volumn 37, Issue 10, 2007, Pages 724-728

  Lim, A ^a   Lydia, A ^b   Rim, H ^c   Dowling, J ^a   Kerr, P ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^c Kosin University   (South Korea)

Author keywords

Campylobacter; Focal segmental glomerulosclerosis; Guillain Barre syndrome; Intravenous immunoglobin

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; BLOOD TESTIS BARRIER; CAMPYLOBACTER; CASE REPORT; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ASSOCIATION; ENTERITIS; FOCAL GLOMERULOSCLEROSIS; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; MALE; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; URINALYSIS;

ADULT; CAMPYLOBACTER INFECTIONS; ENTERITIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GUILLAIN-BARRE SYNDROME; HUMANS; MALE;

EID: 34748841958     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01458.x     Document Type: Article

References (19)

1. Andrews PI, Kainer G, Yong LC, Tobias VH, Rosenberg AR. Glomerulonephritis, pulmonary hemorrhage and anemia associated with Campylobacter jejuni infection. Aust NZ J Med 1989 19 : 721 3.
2. Maidment CG, Evans DB, Coulden RA, Thiru S. Campylobacter enteritis complicated by glomerulonephritis. J Infect 1985 10 : 177 8.
3. Olbricht CJ, Stark E, Helmchen U, Schulze M, Brunkhorst R, Koch KM. Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy: a case report and review of the literature. Nephron 1993 64 : 139 41.
4. Heckmann JG, Bohmer K, Druschky A, Winterholler M, Neundorfer B. Guillain-Barre syndrome in association with focal segmental glomerulosclerosis. Eur Neurol 1998 40 : 114 15.
5. Careless D, Rigby R, Axelsen R, Boyle R. A case of Guillain-Barre syndrome with focal segmental glomerulosclerosis. Am J Nephrol 1993 13 : 160 63.
6. Laurinavicius A, Hurwitz S, Rennke HG. Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int 1999 56 : 2203 13.
7. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 2001 59 : 2126 33.
8. Tomlinson L, Boriskin Y, McPhee I, Holwill S, Rice P. Acute cytomegalovirus infection complicated by collapsing glomerulopathy. Nephrol Dial Transplant 2003 18 : 187 9.
9. Coventry S, Shoemaker LR. Collapsing glomerulopathy in a 16-year-old girl with pulmonary tuberculosis: the role of systemic inflammatory mediators. Pediatr Dev Pathol 2004 7 : 166 70.
10. Pakasa NM, Nseka NM, Nyimi LM. Secondary collapsing glomerulopathy associated with Loa loa filariasis. Am J Kidney Dis 1997 30 : 836 9.
11. Leblond V, Beaufils H, Ginsburg C, Bricaire F, Danis M, Deray G et al. Collapsing focal segmental glomerulosclerosis associated with visceral leishmaniasis. Nephrol Dial Transplant 1994 9 : 1353.
12. Gao JX, Ma BL, Wang WC, Xie YL, Yu H. A mouse model of chronic Campylobacter jejuni infection. Post-infection nephritis. Chin Med J (Engl) 1988 101 : 623 30.
13. Hu L, Bray MD, Osorio M, Kopecko DJ. Campylobacter jejuni induces maturation and cytokine production in human dendritic cells. Infect Immun 2006 74 : 2697 705.
14. Watson RO, Galan JE. Signal transduction in Campylobacter jejuni-induced cytokine production. Cell Microbiol 2005 7 : 655 65.
15. Hickey TE, Majam G, Guerry P. Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect Immun 2005 73 : 5194 7.
16. Wassenaar TM. Toxin production by Campylobacter spp. Clin Micro Rev 1997 10 : 466 76.
17. Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 2006 69 : 920 26.
18. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004 15 : 2169 77.
19. Monova D, Belovezhdov N, Altunkova I, Monov S. Intravenous immunoglobulin G in the treatment of patients with chronic glomerulonephritis: clinical experience lasting 15 years. Nephron 2002 90 : 262 6.